J. Portilla

发表

M. Leal, J. Moltó, F. Pulido, 2011, Clinical drug investigation.

How do women living with HIV experience menopause? Menopausal symptoms, anxiety and depression according to reproductive age in a multicenter cohort

P. L. López, Miguel Ángel Martínez, D. Podzamczer, 2021, BMC Women's Health.

Virological outcome among HIV infected patients transferred from pediatric care to adult units in Madrid, Spain (1997–2017)

P. Soler-Palacín, Á. Holguín, J. Losa, 2020, Scientific Reports.

Doravirine dose Selection and 96-Week Safety and Efficacy versus Efavirenz in Antiretroviral Therapy-Naive Adults with HIV-1 Infection in a Phase IIb Trial

J. Gatell, H. Teppler, F. Raffi, 2019, Antiviral therapy.

Patterns of Antiretroviral Therapy Use and Immunologic Profiles at Enrollment in the REPRIEVE Trial.

G. Bloomfield, M. Kozal, K. Tashima, 2020, The Journal of infectious diseases.

Early lipid changes with atazanavir/ritonavir or darunavir/ritonavir

D. Podzamczer, E. Negredo, E. Martinez, 2014, HIV medicine.

Brief Report: Dolutegravir Plus Abacavir/Lamivudine for the Treatment of HIV-1 Infection in Antiretroviral Therapy-Naive Patients: Week 96 and Week 144 Results From the SINGLE Randomized Clinical Trial

D. Podzamczer, S. Walmsley, J. Kilby, 2015, Journal of acquired immune deficiency syndromes.

Clinical presentation of HIV infection in patients aged 50 years or older.

J. Ena, J. Portilla, M. Masiá, 1998, The Journal of infection.

Drug Toxicity or Syndrome of Immune Restoration Causing Fulminant Cirrhosis After HAART-Induced Immune Recovery

J. Portilla, E. Merino, V. Boix, 2002, European Journal of Clinical Microbiology and Infectious Diseases.

DBP rs16846876 and rs12512631 polymorphisms are associated with progression to AIDS naïve HIV-infected patients: a retrospective study

M. Muñoz-Fernández, M. Riera, J. Jiménez, 2019, Journal of Biomedical Science.

Directly observed therapy for chronic hepatitis C: a randomized clinical trial in the prison setting.

J. Portilla, A. Marco, P. Sáiz de la Hoya, 2014, Gastroenterologia y hepatologia.

[Utility of 2 biochemical models predictive of liver fibrosis grade in prison inmates with hepatitis C].

J. Sánchez-Payá, E. Lissen, J. Portilla, 2009, Gastroenterologia y hepatologia.

Seasonal influenza in octogenarians and nonagenarians admitted to a general hospital: epidemiology, clinical presentation and prognostic factors.

S. Reus, J. Portilla, E. Merino, 2016, Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia.

Reasons for noncompliance with the national guidelines for initial antiretroviral therapy of HIV-infected patients in Spain, 2010-2015.

S. Moreno, J. Berenguer, R. Muga, 2019, Enfermedades infecciosas y microbiologia clinica.

B. Clotet, E. Negredo, R. Lopez-Blazquez, 2010, Antiviral research.

Cytokine levels predict 30-day mortality in octogenarians and nonagenarians with community-acquired pneumonia: a retrospective observational study

J. Ramos-Rincón, G. González-Alcaide, J. Portilla, 2019, European Journal of Clinical Microbiology & Infectious Diseases.

[Influence of Pneumonia Severity Index in the decision-making process in the emergency department].

J. Portilla, P. Llorens, E. Merino, 2014, Enfermedades infecciosas y microbiologia clinica.

Influencia del Pneumonia Severity Index en la toma de decisiones en el servicio de urgencias

J. Portilla, P. Llorens, E. Merino, 2014 .

Association between IL28B gene polymorphisms and plasma HCV-RNA levels in HIV/HCV-co-infected patients

J. Miro, E. Poveda, V. Soriano, 2011, AIDS.

Low-Level HIV Viremia Is Associated With Microbial Translocation and Inflammation

J. Sánchez-Payá, S. Reus, R. Francés, 2013, Journal of acquired immune deficiency syndromes.

Inflammation and Microbial Translocation in Treatment-Controlled HIV Patients

J. Sánchez-Payá, S. Reus, A. Gimeno, 2013, Antiviral therapy.

Vertebral osteomyelitis and epidural abscess in a patient receiving enfuvirtide

S. Reus, J. Portilla, E. Merino, 2004, European Journal of Clinical Microbiology and Infectious Diseases.

Update on intra-abdominal and post-surgical infections

M. Salavert, Á. Asensio, J. Aguado, 2008 .

Valproic acid could help in the fight against COVID-19: A case–control study

J. Sánchez-Payá, S. Reus, J. Portilla, 2022, Neurologia.

Long-Term Changes of Inflammatory Biomarkers in Individuals on Suppressive Three-Drug or Two-Drug Antiretroviral Regimens

A. Muriel, M. López-Huertas, S. Moreno, 2022, Frontiers in Immunology.

Knowledge and Perceived Emotions Regarding an Anal Cancer Preventive Program in People Diagnosed With HIV: A Qualitative Study.

M. Fernández-Alcántara, M. Cabañero‐Martínez, J. Perpiñá-Galvañ, 2022, Cancer nursing.

High Irisin levels in nondiabetic HIV‐infected males are associated with insulin resistance, nonalcoholic fatty liver disease, and subclinical atherosclerosis

J. Sánchez-Payá, S. Reus, J. Portilla, 2018, Clinical endocrinology.

Impact of circulating bacterial DNA in long-term glucose homeostasis in non-diabetic patients with HIV infection: cohort study

S. Reus, R. Francés, J. Portilla, 2018, European Journal of Clinical Microbiology & Infectious Diseases.

Switching from a Toxicity-Causing Antiretroviral to Enfuvirtide in Patients with HIV: The SWITCH TOX Study

S. Staszewski, A. Streinu-Cercel, S. Rugină, 2008, HIV clinical trials.

Safety, Efficacy, and Persistence of Emtricitabine/Tenofovir Versus Other Nucleoside Analogues in Naive Subjects Aged 50 Years or Older in Spain: The TRIP Study

J. Olalla, J. Blanco, M. Riera, 2013 .

Progressive multifocal leukoencephalopathy treated with cidofovir in HIV-infected patients receiving highly active anti-retroviral therapy.

S. Reus, J. Portilla, E. Merino, 2000, The Journal of infection.

Effectiveness of the combination elvitegravir/cobicistat/tenofovir/emtricitabine (EVG/COB/TFV/FTC) plus darunavir among treatment-experienced patients in clinical practice: a multicentre cohort study

D. Podzamczer, C. Vidal, B. Rodés, 2020, AIDS Research and Therapy.

Effectiveness and safety of first-line antiretroviral regimens in clinical practice: a multicentre cohort study.

Miguel Ángel Martínez, D. Podzamczer, C. Vidal, 2020, The Journal of antimicrobial chemotherapy.

[Directly observed treatment of latent tuberculosis infection: comparative study of two isoniazid regimens].

J. Sánchez-Payá, J. Portilla, E. Merino, 2003, Enfermedades infecciosas y microbiologia clinica.

Discovering HIV related information by means of association rules and machine learning

Miguel Ángel Martínez, Juan Martínez-Romo, Lourdes Araujo, 2022, Scientific Reports.

Pharmacokinetics of methadone in human-immunodeficiency-virus-infected patients receiving nevirapine once daily

J. Pérez-Ruixo, J. Portilla, E. Merino, 2007, European Journal of Clinical Pharmacology.

and Cytological Status in a Spanish Cohort Sex with Men by Geographical Origin, Age, Distribution in HIV-Infected Men Who Have Anal Human Papillomavirus Genotype

J. Blanco, C. Rodríguez, P. Viciana, 2014 .

Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Versus Dolutegravir/Abacavir/Lamivudine in Antiretroviral-Naive Adults (SYMTRI): A Multicenter Randomized Open-Label Study (PReEC/RIS-57)

D. Podzamczer, E. Ribera, J. Macías, 2021, Open forum infectious diseases.

Update on bacterial infections in immunosuppressed patients

M. Sanz, A. Solé, M. Salavert, 2007 .

The effects of Maraviroc on liver fibrosis in HIV/HCV co-infected patients

F. Gutiérrez, J. Portilla, M. Montero, 2014, Journal of the International AIDS Society.

Impact of Advanced HIV Disease on Quality of Life and Mortality in the Era of Combined Antiretroviral Treatment

S. Reus, J. Portilla, I. Portilla, 2021, Journal of clinical medicine.

Polyostotic osteitis in secondary syphilis in an HIV-infected patient.

S. Reus, J. Portilla, E. Merino, 2013, Sexually transmitted diseases.

Trends in mortality according to hepatitis C virus serostatus in the era of combination antiretroviral therapy

M. Salavert, F. Vidal, P. Viciana, 2012, AIDS.

Prevalence and factors associated with SARS-CoV-2 seropositivity in the Spanish HIV Research Network Cohort

D. Podzamczer, E. Poveda, J. Arribas, 2021, Clinical Microbiology and Infection.

Biological markers of fertility (inhibin‐B) in HIV‐infected men: influence of HIV infection and antiretroviral therapy

J. Sánchez-Payá, J. Portilla, E. Merino, 2016, HIV medicine.

Relapsing Cutaneous Alternariosis in a Kidney Transplant Recipient Cured with Liposomal Amphotericin B

J. Bañuls, I. Betlloch, A. Franco, 2003, European Journal of Clinical Microbiology and Infectious Diseases.

[Cutaneous drug reactions in HIV-infected patients in the HAART era].

I. Belinchón, M. Blanes, J. Portilla, 2009, Actas dermo-sifiliograficas.

Leishmaniasis as a cause of oral disease in HIV infection.

J. Bañuls, J. Portilla, V. Boix, 1995, AIDS.

[Current prevalence and characteristics of dermatoses associated with human immunodeficiency virus infection].

J. Sánchez-Payá, I. Belinchón, M. Blanes, 2010, Actas dermo-sifiliograficas.

Prevention and treatment of opportunistic infections and other coinfections in HIV-infected patients: May 2015.

D. Podzamczer, J. Mallolas, J. Caylà, 2016, Enfermedades infecciosas y microbiologia clinica.

Consensus document on the management of renal disease in HIV-infected patients.

E. Negredo, J. Miro, E. Martinez, 2014, Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia.

Nosocomial Outbreak of Scabies Clinically Resistant to Lindane

J. Sánchez-Payá, J. Portilla, E. Merino, 1997, Infection Control & Hospital Epidemiology.

Sporobolomyces salmonicolor lymphadenitis in an AIDS patient. Pathogen or passenger?

M. Pérez-Mateo, J. Portilla, V. Boix, 1994, AIDS.

[Visceral leishmaniasis: a comparative study of patients with and without human immunodeficiency virus infection].

S. Reus, J. Portilla, E. Merino, 1999, Enfermedades infecciosas y microbiologia clinica.

Executive summary: Prevention and treatment of opportunistic infections and other coinfections in HIV-infected patients: May 2015.

D. Podzamczer, J. Mallolas, J. Caylà, 2016, Enfermedades infecciosas y microbiologia clinica.

Usefulness of pp65 Antigenemia for the Early Diagnosis of Cytomegalovirus Disease in Patients with AIDS

J. Sánchez-Payá, I. Hernández-Aguado, A. Gimeno, 1999, European Journal of Clinical Microbiology and Infectious Diseases.

Switching to DTG/3TC fixed-dose combination (FDC) Is non-inferior to continuing a TAF-based regimen in maintaining virologic suppression through 48 weeks (TANGO Study)

J. Routy, J. V. Wyk, M. Aboud, 2020 .

Increasing incidence of hepatocellular carcinoma in HIV-infected patients in Spain.

J. Pineda, A. Rivero, J. Portilla, 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Effectiveness of boosted darunavir plus rilpivirine in patients with long-lasting HIV-1 infection: DARIL study.

E. Martinez, J. Navarro, A. Curran, 2020, The Journal of antimicrobial chemotherapy.

Switching to lopinavir/ritonavir with or without abacavir/lamivudine in lipoatrophic patients treated with zidovudine/abacavir/lamivudine.

F. Pulido, P. Domingo, A. Ocampo, 2013, The Journal of antimicrobial chemotherapy.

Can alprostadil improve liver failure in HIV-infected patients with severe acute viral hepatitis?

S. Reus, J. Portilla, V. Boix, 1998, The Journal of infection.

Incidence of Hepatitis C Virus (HCV) in a Multicenter Cohort of HIV-Positive Patients in Spain 2004–2011: Increasing Rates of HCV Diagnosis but Not of HCV Seroconversions

J. del Romero, J. Blanco, F. Segura, 2014, PloS one.

[Predictive markers of HIV and HCV infection and co-infection among inmates in a Spanish prison].

J. Sánchez-Payá, J. Cebriá, J. Portilla, 2005, Enfermedades infecciosas y microbiologia clinica.

Differential body composition effects of protease inhibitors recommended for initial treatment of HIV infection: a randomized clinical trial.

D. Podzamczer, E. Negredo, J. Gatell, 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Lopinavir-ritonavir monotherapy versus lopinavir-ritonavir and two nucleosides for maintenance therapy of HIV

J. Arribas, R. Delgado, M. Pérez-Elías, 2008, AIDS.

Relationship between plasma bilirubin level and oxidative stress markers in HIV‐infected patients on atazanavir‐ vs. efavirenz‐based antiretroviral therapy

E. Martinez, C. Viladés, J. Berenguer, 2016, HIV medicine.

Risk factors for loss of virological suppression in patients receiving lopinavir/ritonavir monotherapy for maintenance of HIV suppression

D. Podzamczer, B. Clotet, J. Arribas, 2009, Antiviral therapy.

Dual treatment with lopinavir-ritonavir plus lamivudine versus triple treatment with lopinavir-ritonavir plus lamivudine or emtricitabine and a second nucleos(t)ide reverse transcriptase inhibitor for maintenance of HIV-1 viral suppression (OLE): a randomised, open-label, non-inferiority trial.

D. Podzamczer, J. Gatell, J. Mallolas, 2015, The Lancet. Infectious diseases.

Lack of short-term increase in serum mediators of fibrogenesis and in non-invasive markers of liver fibrosis in HIV/hepatitis C virus-coinfected patients starting maraviroc-based antiretroviral therapy

J. Macías, J. Pineda, Á. Camacho, 2012, European Journal of Clinical Microbiology & Infectious Diseases.

[Predictors of progression and death in patients with advanced HIV infection in the era of highly active antiretroviral therapy].

J. Sánchez-Payá, S. Reus, O. Martínez-Madrid, 2004, Enfermedades infecciosas y microbiologia clinica.

Simplification to dual therapy (atazanavir/ritonavir + lamivudine) versus standard triple therapy [atazanavir/ritonavir + two nucleos(t)ides] in virologically stable patients on antiretroviral therapy: 96 week results from an open-label, non-inferiority, randomized clinical trial (SALT study)

B. Clotet, M. Odriozola, J. Olalla, 2017, The Journal of antimicrobial chemotherapy.

Fluconazole plus allopurinol in treatment of visceral leishmaniasis.

M. Pérez-Mateo, J. Portilla, V. Boix, 1996, The Journal of antimicrobial chemotherapy.

[Pancreas and HIV infection].

J. Portilla, V. Boix, 1994, Medicina clinica.

Subclinical atherosclerosis in low Framingham risk HIV patients

J. Sánchez-Payá, S. Reus, J. Portilla, 2017, European journal of clinical investigation.

[Infectious diseases in the adult population admitted to a general hospital].

J. Portilla, E. Merino, J. Ramos, 2015, Enfermedades infecciosas y microbiologia clinica.

Empirical monotherapy with meropenem or combination therapy: the microbiological point of view

J. Sánchez-Payá, M. Santibáñez, J. Portilla, 2016, European Journal of Clinical Microbiology & Infectious Diseases.

The algorithm used for the interpretation of doravirine transmitted drug resistance strongly influences clinical practice and guideline recommendations.

Miguel Ángel Martínez, J. Olalla, A. Aguilera, 2020, Journal of Antimicrobial Chemotherapy.

Measles in adults during an outbreak in Spain: hospitalization associated with gastrointestinal and liver involvement

S. Reus, J. Portilla, E. Merino, 2014, Infection.

Executive summary of the GeSIDA/National AIDS Plan consensus document on antiretroviral therapy in adults infected by the human immunodeficiency virus (updated January 2014).

D. Podzamczer, B. Clotet, J. Gatell, 2014, Enfermedades infecciosas y microbiologia clinica.

Immunovirologic consequences and safety of short, non-structured interruptions of successful antiretroviral treatment.

J. Sánchez-Payá, S. Reus, A. Gimeno, 2007, The Journal of infection.

Lopinavir-Ritonavir Monotherapy Versus Lopinavir-Ritonavir and 2 Nucleosides for Maintenance Therapy of HIV: 96-Week Analysis

J. Arribas, R. Delgado, M. Pérez-Elías, 2009, Journal of acquired immune deficiency syndromes.

Combined Effect of Sex and Age in Response to Antiretroviral Therapy in HIV-Infected Patients

J. Blanco, S. Moreno, M. Pérez-Elías, 2016, Antiviral therapy.

Impact of an enhanced screening program on the detection of non-AIDS neoplasias in patients with human immunodeficiency virus infection

D. Podzamczer, J. Mallolas, J. Losa, 2021, Trials.

Anal Human Papillomavirus Genotype Distribution in HIV-Infected Men Who Have Sex with Men by Geographical Origin, Age, and Cytological Status in a Spanish Cohort

J. del Romero, J. Blanco, B. Hernández-Novoa, 2013, Journal of Clinical Microbiology.

Chemsex Practices and Health-Related Quality of Life in Spanish Men with HIV Who Have Sex with Men

R. Ferrer-Cascales, J. Portilla, N. Ruiz-Robledillo, 2021, Journal of clinical medicine.

Effects of first-line antiretroviral therapy on the CD4/CD8 ratio and CD8 cell counts in CoRIS: a prospective multicentre cohort study.

A. Muriel, S. Moreno, M. Vivancos, 2020, The lancet. HIV.

Prevalence of M184V and K65R in proviral DNA from PBMCs in HIV-infected youths with lamivudine/emtricitabine exposure

P. Soler-Palacín, Á. Holguín, J. Losa, 2021, The Journal of antimicrobial chemotherapy.

COVID‐19 in hospitalized HIV‐positive and HIV‐negative patients: A matched study

J. Arribas, J. Blanco, S. Moreno, 2021, HIV medicine.

International Congress of Drug Therapy in HIV Infection 2‐6 November 2014, Glasgow, UK

Samit R. Joshi, Charlene A Flash, Thomas Lengauer, 2014 .

Dual Therapy With Darunavir and Ritonavir Plus Lamivudine vs Triple Therapy With Darunavir and Ritonavir Plus Tenofovir Disoproxil Fumarate and Emtricitabine or Abacavir and Lamivudine for Maintenance of Human Immunodeficiency Virus Type 1 Viral Suppression: Randomized, Open-Label, Noninferiority DU

D. Podzamczer, B. Clotet, E. Negredo, 2017, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[Disseminated candidiasis with pulmonary involvement].

J. Portilla, A. Candela, A. Zarco, 1991, Revista clinica espanola.

La formación de grado en enfermedades infecciosas, resistencia y uso de antibióticos desde la perspectiva de los estudiantes de Medicina

O. Dyar, J. Rodríguez-Baño, C. Pulcini, 2018, Enfermedades Infecciosas y Microbiología Clínica.

Perspective of Spanish medical students regarding undergraduate education in infectious diseases, bacterial resistance and antibiotic use.

O. Dyar, J. Rodríguez-Baño, C. Pulcini, 2018, Enfermedades infecciosas y microbiologia clinica.

Perspective of Spanish medical students regarding undergraduate education in infectious diseases, bacterial resistance and antibiotic use

O. Dyar, J. Rodríguez-Baño, C. Pulcini, 2019, Enfermedades infecciosas y microbiologia clinica (English ed.).

Is Visceral Leishmaniasis Different in Immunocompromised Patients Without Human Immunodeficiency Virus? A Comparative, Multicenter Retrospective Cohort Analysis.

M. Salavert, S. Reus, M. Blanes, 2017, The American journal of tropical medicine and hygiene.

Prevalence of Trypanosoma cruzi infection in Latin American pregnant women and level of compliance of the Valencian Health Programme in the city of Alicante

M. Andreu, J. Portilla, D. Torrús, 2013, Epidemiology and Infection.

Risk factors for sexual and erectile dysfunction in HIV-infected men: the role of protease inhibitors

J. Sánchez-Payá, S. Reus, J. Portilla, 2010, AIDS.

Erectile dysfunction among HIV-infected men is associated with protease inhibitor containing HAART

J. Portilla, A. Picó, E. Merino, 2009 .

Liver tolerance of raltegravir-containing antiretroviral therapy in HIV-infected patients with chronic hepatitis C.

J. Macías, J. Pineda, A. Rivero, 2011, Journal of Antimicrobial Chemotherapy.

Hepatic safety of tipranavir plus ritonavir (TPV/r)-based antiretroviral combinations: effect of hepatitis virus co-infection and pre-existing fibrosis.

J. Macías, J. Pineda, A. Rivero, 2008, The Journal of antimicrobial chemotherapy.

The quick Sepsis-related Organ Failure Assessment (qSOFA) is a good predictor of in-hospital mortality in very elderly patients with bloodstream infections: A retrospective observational study

J. Ramos-Rincón, A. Gimeno, J. Portilla, 2019, Scientific Reports.

[Carotid artery disease and human immunodeficiency virus (HIV) infection].

J. Portilla, C. Serna-Candel, J. Matías-Guiu, 2009, Neurologia.

Fournier's Gangrene in HIV-Infected Patients

S. Reus, J. Portilla, E. Merino, 2001, European Journal of Clinical Microbiology and Infectious Diseases.

Acalculous cholecystitis associated with Plasmodium falciparum malaria.

J. Portilla, E. Merino, V. Boix, 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Impact of vitamin D insufficiency on insulin homeostasis and beta cell function in nondiabetic male HIV‐infected patients

J. Sánchez-Payá, S. Reus, Á. Bernabeu, 2013, HIV medicine.

Primary resistance to integrase strand transfer inhibitors in Spain using ultrasensitive HIV-1 genotyping.

R. Paredes, D. Podzamczer, M. Noguera-Julián, 2020, The Journal of antimicrobial chemotherapy.

Use of cohort data to estimate national prevalence of transmitted drug resistance to antiretroviral drugs in Spain (2007-2012).

F. García, R. Delgado, J. Blanco, 2015, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Physicians' opinions on generic antiretroviral drugs and single-tablet regimen de-simplification for the treatment of HIV infection: a multicentre survey in Spain.

P. L. López, Miguel Ángel Martínez, D. Podzamczer, 2019, The Journal of antimicrobial chemotherapy.

Low CD4/CD8 ratio is associated with increased morbidity and mortality in late and non-late presenters: results from a multicentre cohort study, 2004–2018

D. Podzamczer, J. Olalla, M. Rava, 2022, BMC Infectious Diseases.

[Aortic endocarditis due to Capnocytophaga sputigena].

J. Portilla, V. Boix, D. Torrús, 1995, Medicina clinica.

Prevalence of high-risk HPV genotypes, categorised by their quadrivalent and nine-valent HPV vaccination coverage, and the genotype association with high-grade lesions

P. Parás-Bravo, M. Santibáñez, J. Portilla, 2018, BMC Cancer.

Functional status determined by Barthel Index predicts community acquired pneumonia mortality in general population.

J. Sánchez-Payá, S. Reus, J. Portilla, 2010, The Journal of infection.

Prevalence of HIV-1 drug resistance mutations among Spanish prison inmates

J. Sánchez-Payá, S. Moreno, J. Portilla, 2006, European Journal of Clinical Microbiology and Infectious Diseases.

Abnormalities in the metabolism of acetaminophen in patients infected with the human immunodeficiency virus (HIV).

M. Pérez-Mateo, J. Portilla, V. Boix, 1997, Methods and findings in experimental and clinical pharmacology.

The Role of Mental Health Conditions in the Diagnosis of Neurocognitive Impairment in People Living with HIV

R. Ferrer-Cascales, J. Portilla, N. Ruiz-Robledillo, 2020, Diagnostics.

Non-immune haemolytic anaemia in a patient with acute hepatitis B

J. Portilla, Julia Portilla-Tamarit, Antonio Amo-Lozano, 2021, Medicina Clínica (English Edition).

Executive summary of the GESIDA/National AIDS Plan Consensus Document on antiretroviral therapy in adults infected by the human immunodeficiency virus (updated January 2015).

D. Podzamczer, B. Clotet, J. Gatell, 2015, Enfermedades Infecciosas y Microbiologia Clinica.

Surgical procedure to prevent gastroesophageal reflux.

J. Portilla, F. Hidalgo, A. Rivera, 1971, American journal of surgery.

Vitamin D insufficiency and subclinical atherosclerosis in non-diabetic males living with HIV

J. Sánchez-Payá, S. Reus, J. Portilla, 2014, Journal of the International AIDS Society.

Seguridad y tolerabilidad de etravirina

J. Portilla, 2009 .

The determination of total testosterone and free testosterone (RIA) are not applicable to the evaluation of gonadal function in HIV-infected males.

J. Sánchez-Payá, J. Portilla, M. Maurí, 2010, The journal of sexual medicine.

Avascular necrosis of the bone in HIV-infected patients: incidence and associated factors.

J. Flores, F. Gutiérrez, J. Portilla, 2002, AIDS.

Latin American Origin Is Not Associated with Worse Outcomes among Hospitalized Patients with COVID-19 in a Public Healthcare System

J. Sánchez-Payá, S. Reus, J. Portilla, 2021, Microorganisms.

Neurocognitive Impairment in Well-Controlled HIV-Infected Patients: A Cross-Sectional Study.

S. Reus, J. Portilla, E. Merino, 2019, AIDS research and human retroviruses.

[Chronic hepatitis C virus infection and associated liver disease among the inmates of a Spanish prison].

J. Sánchez-Payá, S. Reus, J. Portilla, 2009, Enfermedades infecciosas y microbiologia clinica.

DBP rs16846876 and rs12512631 polymorphisms are associated with progression to AIDS naïve HIV-infected patients: a retrospective study

M. Muñoz-Fernández, M. Riera, C. Rodríguez, 2019, Journal of Biomedical Science.

J. Macías, J. Pineda, Á. Camacho, 2012, European Journal of Clinical Microbiology & Infectious Diseases.

CD4 recovery is associated with genetic variation in IFNγ and IL19 genes.

J. Benito, J. Blanco, Y. Pacheco, 2019, Antiviral research.

Neurocognitive safety after 96 weeks on dual therapy with atazanavir/ritonavir plus lamivudine: results of the neurocognitive substudy of the SALT randomized clinical trial

J. De La Torre, J. Prada, S. Reus, 2018, The Journal of antimicrobial chemotherapy.

Reasons for noncompliance with the national guidelines for initial antiretroviral therapy of HIV-infected patients in Spain, 2010–2015

S. Moreno, J. Berenguer, R. Muga, 2019, Enfermedades infecciosas y microbiologia clinica (English ed.).

[Mortality from chronic liver disease in patients with HIV infection].

R. Jover, J. Portilla, V. Boix, 1995, Medicina clinica.

J. Portilla, V. Estrada, 2011, AIDS reviews.

Contribution of Oxidative Stress to Non-AIDS Events in HIV-Infected Patients

F. Vidal, S. Moreno, X. Barber, 2017, Journal of acquired immune deficiency syndromes.

[Mechanism of action and pharmacokinetics of rilpivirine].

J. Portilla, V. Estrada, 2013, Enfermedades infecciosas y microbiologia clinica.

Meglumine antimoniate-induced pancreatitis.

M. Pérez-Mateo, J. Portilla, V. Boix, 1996, The American journal of gastroenterology.

Genotypic tropism testing of proviral DNA to guide maraviroc initiation in aviraemic subjects: 48‐week analysis of results from the PROTEST study

R. Paredes, D. Podzamczer, E. Poveda, 2017, HIV medicine.

Angiolipomas, a rare manifestation of HIV-associated lipodystrophy.

I. Belinchón, M. Blanes, J. Portilla, 2008, AIDS.

Prevalence of high-risk HPV genotypes, categorised by their quadrivalent and nine-valent HPV vaccination coverage, and the genotype association with high-grade lesions

Joaquín Portilla, P. Parás-Bravo, M. Santibáñez, 2018, BMC Cancer.

Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Versus Dolutegravir/Abacavir/Lamivudine in Antiretroviral-Naive Adults (SYMTRI): A Multicenter Randomized Open-Label Study (PReEC/RIS-57)

D. Podzamczer, J. Macías, S. Moreno, 2021, Open forum infectious diseases.

Expanding HIV clinical monitoring: the role of CD4, CD8, and CD4/CD8 ratio in predicting non-AIDS events

Miguel Ángel Martínez, B. Rodés, E. Poveda, 2023, EBioMedicine.

Predictors of low‐level HIV viraemia and virological failure in the era of integrase inhibitors: A Spanish nationwide cohort

E. Poveda, A. Rivero, M. Rava, 2022, HIV medicine.

Evaluation of the validity of the HPV viral load compared to conventional techniques for the detection of high-grade anal intraepithelial lesions in men with HIV who have sex with men

M. Cabañero‐Martínez, J. Portilla, M. Díez-Martínez, 2023, PeerJ.

Effectiveness and safety of first-line antiretroviral regimens in clinical practice: a multicentre cohort study.

Miguel Ángel Martínez, D. Podzamczer, C. Vidal, 2020, The Journal of antimicrobial chemotherapy.

Safety, efficacy, and persistence of emtricitabine/tenofovir versus other nucleoside analogues in naive subjects aged 50 years or older in Spain: the TRIP study.

J. Olalla, J. Blanco, M. Riera, 2013, HIV Clinical Trials.

Impact of an enhanced screening program on the detection of non-AIDS neoplasias in patients with human immunodeficiency virus infection

D. Podzamczer, J. Mallolas, J. Losa, 2021, Trials.

Executive summary of the GeSIDA/National AIDS Plan consensus document on antiretroviral therapy in adults infected by the human immunodeficiency virus (updated January 2018).

D. Podzamczer, E. Negredo, J. Miro, 2019, Enfermedades infecciosas y microbiologia clinica.

Increasing incidence of hepatocellular carcinoma in HIV-infected patients in Spain.

J. Pineda, A. Rivero, J. Portilla, 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Functional status determined by Barthel Index predicts community acquired pneumonia mortality in general population.

J. Sánchez-Payá, S. Reus, J. Portilla, 2010, The Journal of infection.

[Safety and tolerability of etravirine].

J. Portilla, 2009, Enfermedades Infecciosas y Microbiologia Clinica.

Consensus document on the management of renal disease in HIV-infected patients.

E. Negredo, J. Miro, E. Martinez, 2014, Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia.

Highly active antiretroviral therapy for patients with tuberculosis: the solution or the problem?

J. Portilla, E. Merino, V. Boix, 2002, AIDS.